Category: Mergers & AcquisitionsSyndicate content

FTC gives Medtronic, Covidien merger the green light

November 26, 2014 by Brian Johnson

The U.S. Federal Trade Commission has approved the pending $43 billion merger between Medtronic  and Covidien, according to regulatory filings.

Report: Medtronic readies $10B bond flotation for Covidien deal

Stryker may bid for Smith & Nephew following 6-month no-bid period | The week in medtech M&A

November 26, 2014 by MassDevice

Here's a look at some of the top mergers & acquisitions stories for medical device companies this week: Will Stryker bid on Smith & Nephew this week?: J&J demands $7.2 billion from Boston Scientific as trial begins; Will Orange County's medtech scene lose its juice without Allergan?; BD-CareFusion deal passes US anti-trust waiting period; Sources: Stryker weighs bid for Smith & Nephew

Will Stryker bid on Smith & Nephew this week?

November 24, 2014 by Brad Perriello

Abaxis buys UK distributor

November 26, 2014 by Val Kennedy

Abaxis says it bought QCR & Trio Diagnostics, the company's distribution partner for veterinary products in the U.K. and Ireland.

Abaxis buys UK distributor

Abaxis said it bought QCR & Trio Diagnostics, its distribution partner for veterinary products in the U.K. and Ireland.

The deal closed on Nov. 17, Abaxis said. Financial terms were not disclosed.

BD plans to use more cash, less debt for $12B CareFusion buy

November 25, 2014 by Brad Perriello

Becton Dickinson plans to cut the debt load from its $12 billion acquisition of CareFusion by some $1.4 billion after realizing it has more cash available that it thought.

BD plans to use more cash, less debt for $12B CareFusion buy

Report: Bayer explores sale of diabetes device unit

November 25, 2014 by MassDevice

Bayer is reportedly exploring a sale of its diabetes device business, which could fetch as much as $2.5 billion from interested private equity buyers.

Report: Bayer explores sale of diabetes device unit

(Reuters) — Bayer (PINK:BAYRY) is considering the sale of its diabetes device business, Bloomberg reported, citing sources.

Sources: Stryker weighs bid for Smith & Nephew

November 24, 2014 by MassDevice

Anonymous sources confirm speculation that Stryker is weighing a bid for British orthopedics rival Smith & Nephew.

Sources: Stryker weighs bid for Smith & Nephew

Will Stryker bid on Smith & Nephew this week?

November 24, 2014 by Brad Perriello

Speculation mounts again about a possible Stryker offer for Smith & Nephew now that a 6-month no-bid period has ended.

Will Stryker bid on Smith & Nephew this week?

UPDATED Nov. 24 with analysis from Morgan Stanley.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp